Back
Oramed Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.37
Seasonality Move:
7.33%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight selling pressure.
Oramed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.43 | Sell |
| 50-day SMA: | 2.37 | Sell |
| 200-day SMA: | 2.42 | Sell |
| 8-day EMA: | 2.39 | Sell |
| 20-day EMA: | 2.4 | Sell |
| 50-day EMA: | 2.39 | Sell |
| 200-day EMA: | 2.48 | Sell |
Oramed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 47.37 | Sell |
| Chaikin Money Flow: | -22792 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.36 - 2.48) | Sell |
| Bollinger Bands (100): | (2.31 - 2.45) | Sell |
Oramed Pharmaceuticals Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oramed Pharmaceuticals Stock
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.37 while ORMP 8-day simple moving average is 2.39, which is a Sell signal.
-
The stock price of ORMP is 2.37 while Oramed Pharmaceuticals 20-day SMA is 2.43, which makes it a Sell.
-
Oramed Pharmaceuticals 50-day simple moving average is 2.37 while ORMP share price is 2.37, making it a Sell technically.
-
ORMP stock price is 2.37 and Oramed Pharmaceuticals 200-day simple moving average is 2.42, creating a Sell signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a SellThe current Oramed Pharmaceuticals [ORMP] share price is $2.37. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals Stock Info
Market Cap:
95.5M
Price in USD:
2.37
Share Volume:
126.4K
Oramed Pharmaceuticals 52-Week Range
52-Week High:
3.67
52-Week Low:
2.00
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Oramed Pharmaceuticals Share Price Forecast
-
What is the Oramed Pharmaceuticals stock price today?The Oramed Pharmaceuticals stock price is 2.37 USD today.
-
Will ORMP stock go up or go down?Oramed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Oramed Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals is overvalued.
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.37 while ORMP 8-day exponential moving average is 2.39, which is a Sell signal.
-
The stock price of ORMP is 2.37 while Oramed Pharmaceuticals 20-day EMA is 2.40, which makes it a Sell.
-
Oramed Pharmaceuticals 50-day exponential moving average is 2.39 while ORMP share price is 2.37, making it a Sell technically.
-
ORMP stock price is 2.37 and Oramed Pharmaceuticals 200-day simple moving average is 2.48, creating a Sell signal.
Fundamental Analysis of Oramed Pharmaceuticals
Is Oramed Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Oramed Pharmaceuticals
Should I short Oramed Pharmaceuticals stock?
-
ORMP Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Oramed Pharmaceuticals is a Sell
-
Oramed Pharmaceuticals Relative Strength Index (RSI) is 47.37, which suggest Oramed Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Oramed Pharmaceuticals is (2.36 - 2.48), which suggest Oramed Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Oramed Pharmaceuticals is (2.31 - 2.45), which suggest Oramed Pharmaceuticals is a Sell
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.